Latest filing published 22 Jun 2021 for Acutus Medical, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Shahzad Malik: trading record in brief
Shahzad Malik (board member) discloses dealings in 6 companies, chiefly Aravive, Inc., Iterum Therapeutics plc and Axonics, Inc. The record holds 41 filings, for trades running from 30 July 2013 to 17 June 2021.
On the open market, the record shows 5 purchases worth €5.9M and 9 sales worth €18.3M. Netting one side against the other leaves €12.3M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 8 share grants.
The median purchase comes to €912k.
The latest filing, published on 22 June 2021, reports a share grant in Acutus Medical, Inc. The last purchase on record was published on 30 May 2018, which is 3,085 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Shahzad Malik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,800 shares0Common StockSEC:0000950103-21-009179:0
- 65,436 shares0Common StockSEC:0000950103-20-015723:0
- 1,551,713 shares0Common StockSEC:0000950103-20-015723:1
- 2,222 shares0Common StockSEC:0000950103-20-015478:0
- 2,500 shares0Common StockSEC:0000899243-18-030610:0
- 43,822 sharesCommon StockSEC:0000899243-18-028108:0
- 1,231,178 sharesCommon StockSEC:0000899243-18-028108:1
- 14,412 sharesCommon StockSEC:0000899243-18-028108:2
- 404,937 sharesCommon StockSEC:0000899243-18-028108:3
- 13,921 sharesOrdinary SharesSEC:0001209191-18-034208:0
- 7,771 sharesOrdinary SharesSEC:0001209191-18-034208:1
- 8,144 shares@ US$13.00Ordinary SharesSEC:0001209191-18-034208:2Canonical exit: 28 Aug 2018 (T+90)
- 391,147 sharesOrdinary SharesSEC:0001209191-18-034208:3
- 218,338 sharesOrdinary SharesSEC:0001209191-18-034208:4
- 228,840 shares@ US$13.00Ordinary SharesSEC:0001209191-18-034208:5Canonical exit: 28 Aug 2018 (T+90)
- 11,200 shares0Common StockSEC:0001209191-17-067098:0
- 3,480 shares0Common StockSEC:0001209191-17-038231:0
- 97,303 shares@ US$18.5015.1% of flowCommon StockSEC:0001209191-17-021497:0
- 386,367 shares@ US$18.0158.1% of flowCommon StockSEC:0001209191-17-021497:1
- 16,330 shares@ US$19.422.7% of flowCommon StockSEC:0001209191-17-020872:0
- 100 shares@ US$19.030.0% of flowCommon StockSEC:0001209191-17-020872:1
- 46,778 shares@ US$19.007.5% of flowCommon StockSEC:0001209191-17-020872:2
- 103,122 shares@ US$19.0816.7% of flowCommon StockSEC:0001209191-17-020872:3
- 4,625 shares0Common StockSEC:0001209191-16-122271:0
- 4,575 shares0Common StockSEC:0001209191-15-058262:0
25 of 35 declarations
